Estrogen Preferentially Promotes the Differentiation of CD11c+ CD11bintermediate Dendritic Cells from Bone Marrow Precursors

Journal of Immunology

Volumn 172, Issue 3, 2004, Pages 1426-1436

  Paharkova Vatchkova, Vladislava ^a   Maldonado, Ruben ^a   Kovats, Susan ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; CD11B ANTIGEN; CD4 ANTIGEN; CD86 ANTIGEN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; FULVESTRANT; GLYCOPROTEIN P 15095; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SEX HORMONE; TAMOXIFEN;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; BONE MARROW; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; IMMUNE RESPONSE; IMMUNOBLOTTING; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 1642526008     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.3.1426     Document Type: Article

References (61)

1. Whitacre, C. C., S. C. Reingold, and P. A. O'Looney. 1999. A gender gap in autoimmunity. Science 283:1277.
2. Barna, M., T. Komatsu, Z. Bi, and C. S. Reiss. 1996. Sex differences in susceptibility to viral infection of the central nervous system. J. Neuroimmunol. 67:31.
3. Kappel, C. A., R. W. Melvold, and B. S. Kim. 1990. Influence of sex on susceptibility in the Theiler's murine encephalomyelitis virus model for multiple sclerosis. J. Neuroimmunol. 29:15.
4. Han, X., P. Lundberg, B. Tanamachi, H. Openshaw, J. Longmate, and E. Cantin. 2001. Gender influences herpes simplex virus type 1 infection in normal and γ interferon-mutant mice. J. Virol. 75:3048.
5. Dalal, M., S. Kim, and R. R. Voskuhl. 1997. Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response. J. Immunol. 159:3.
6. Bebo, B. F., Jr., J. C. Schuster, A. A. Vandenbark, and H. Offner. 1999. Androgens alter the cytokine profile and reduce encephalitogenicity of myelin-reactive T cells. J. Immunol. 162:35.
7. Padgett, D. A., R. M. Loria, and J. F. Sheridan. 1997. Endocrine regulation of the immune response to influenza virus infection with a metabolite of DHEA-androstenediol. J. Neuroimmunol. 78:203.
8. Bebo, B. F., Jr., A. Fyfe-Johnson, K. Adlard, A. G. Beam, A. A. Vandenbark, and H. Offner. 2001. Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains. J. Immunol. 166:2080.
9. Kim, S., S. M. Liva, M. A. Dalal, M. A. Verity, and R. R. Voskuhl. 1999. Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis. Neurology 52:1230.
10. Komi, J., and O. Lassila. 2000. Nonsteroidal anti-estrogens inhibit the functional differentiation of human monocyte-derived dendritic cells. Blood 95:2875.
11. Olsen, N. J., and W. J. Kovacs. 1996. Gonadal steroids and immunity. Endocr. Rev. 17:369.
12. Hall, J. M., J. F. Couse, and K. S. Korach. 2001. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J. Biol. Chem. 276:36869.
13. McDonnell, D. P., and J. D. Norris. 2002. Connections and regulation of the human estrogen receptor. Science 296:1642.
14. Couse, J. F., J. Lindzey, K. Grandien, J. A. Gustafsson, and K. S. Korach. 1997. Tissue distribution and quantitative analysis of estrogen receptor-α (ERα) and estrogen receptor-β (ERβ) messenger ribonucleic acid in the wild-type and ERα-knockout mouse. Endocrinology 138:4613.
15. Couse, J. F., and K. S. Korach. 1999. Estrogen receptor null mice: what have we learned and where will they lead us? Endocr. Rev. 20:358.
16. Howell, A., C. K. Osborne, C. Morris, and A. E. Wakeling. 2000. ICI 182, 780 (Faslodex): development of a novel. "pure" antiestrogen. Cancer 89:817.
17. Dutertre, M., and C. L. Smith. 2000. Molecular mechanisms of selective estrogen receptor modulator (SERM) action. J. Pharmacol. Exp. Ther. 295:431.
18. Shang, Y., and M. Brown. 2002. Molecular determinants for the tissue specificity of SERMs. Science 295:2465.
19. Kaushic, C., F. Zhou, A. D. Murdin, and C. R. Wira. 2000. Effects of estradiol and progesterone on susceptibility and early immune responses to Chlamydia trachomatis infection in the female reproductive tract. Infect. Immun. 68:4207.
20. Salem, M. L., G. Matsuzaki, K. Kishihara, G. A. Madkour, and K. Nomoto. 2000. β-Estradiol suppresses T cell-mediated delayed-type hypersensitivity through suppression of antigen-presenting cell function and Th1 induction. Int. Arch. Allergy Immunol. 121:161.
21. Saito, S., M. L. Foegh, N. Motomura, H. Lou, K. Kent, and P. W. Ramwell. 1998. Estradiol inhibits allograft-inducible major histocompatibility complex class II antigen expression and transplant arteriosclerosis in the absence of immunosuppression. Transplantation 66:1424.
22. Wilcoxen, S. C., E. Kirkman, K. C. Dowdell, and S. A. Stohlman. 2000. Gender-dependent IL-12 secretion by APC is regulated by IL-10. J. Immunol. 164:6237.
23. Liu, H. Y., A. C. Buenafe, A. Matejuk, A. Ito, A. Zamora, J. Dwyer, A. A. Vandenbark, and H. Offner. 2002. Estrogen inhibition of EAE involves effects on dendritic cell function. J. Neurosci. Res. 70:238.
24. Wira, C. R., M. A. Roche, and R. M. Rossoll. 2002. Antigen presentation by vaginal cells: role of TGFβ as a mediator of estradiol inhibition of antigen presentation. Endocrinology 143:2872.
25. Prabhala, R. H., and C. R. Wira. 1995. Sex hormone and IL-6 regulation of antigen presentation in the female reproductive tract mucosal tissues. J. Immunol. 155:5566.
26. Hoek, A., W. Allaerts, P. J. Leenen, J. Schoemaker, and H. A. Drexhage. 1997. Dendritic cells and macrophages in the pituitary and the gonads: evidence for their role in the fine regulation of the reproductive endocrine response. Eur. J. Endocrinol. 136:8.
27. Liu, J. W., D. D. Dawson, C. E. Peters, M. A. Baker, and A. M. Walker. 1997. Estrogen replacement in ovariectomized rats results in physiologically significant levels of circulating progesterone, and co-administration of progesterone markedly reduces the circulating estrogen. Endocrine 6:125.
28. Miller, L., and J. S. Hunt. 1998. Regulation of TNF-α production in activated mouse macrophages by progesterone. J. Immunol. 160:5098.
29. Gilmore, W., L. P. Weiner, and J. Correale. 1997. Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects. J. Immunol. 158:446.
30. Lanzavecchia, A., and F. Sallusto. 2001. The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics. Curr. Opin. Immunol. 13:291.
31. Mellman, I., and R. M. Steinman. 2001. Dendritic cells: specialized and regulated antigen processing machines. Cell 106:255.
32. Shortman, K., and Y. J. Liu. 2002. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2:151.
33. Manz, M. G., D. Traver, T. Miyamoto, I. L. Weissman, and K. Akashi. 2001. Dendritic cell potentials of early lymphoid and myeloid progenitors. Blood 97:3333.
34. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176:1693.
35. Lutz, M. B., N. Kukutsch, A. L. Ogilvie, S. Rossner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223:77.
36. Qin, Z., G. Noffz, M. Mohaupt, and T. Blankenstein. 1997. Interleukin-10 prevents dendritic cell accumulation and vaccination with granulocyte-macrophage colony-stimulating factor gene-modified tumor cells. J. Immunol. 159:770.
37. Dongre, A. R., S. Kovats, P. deRoos, A. L. McCormack, T. Nakagawa, V. Paharkova-Vatchkova, J. Eng, H. Caldwell, J. R. Yates III, and A. Y. Rudensky. 2001. In vivo MHC class II presentation of cytosolic proteins revealed by rapid automated tandem mass spectrometry and functional analyses. Eur. J. Immunol. 31:1485.
38. Shastri, N., G. Gammon, S. Horvath, A. Miller, and E. E. Sercarz. 1986. The choice between two distinct T cell determinants within a 23-amino acid region of lysozyme depends on their structural context. J. Immunol. 137:911.
39. Kappler, J. W., B. Skidmore, J. White, and P. Marrack. 1981. Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas: lack of independent antigen and H-2 recognition. J. Exp. Med. 153:1198.
40. Kovats, S., G. T. Nepom, M. Coleman, B. Nepom, W. W. Kwok, and J. S. Blum. 1995. Deficient antigen-presenting cell function in multiple genetic complementation groups of type II bare lymphocyte syndrome. J. Clin. Invest. 96:217.
41. Vremec, D., J. Pooley, H. Hochrein, L. Wu, and K. Shortman. 2000. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J. Immunol. 164:2978.
42. Wilkinson, R. F. 1993. The effect of charcoal/dextran treatment on select serum components. In Art to Science in Tissue Culture (Hyclone), Vol. 12. Hyclone Laboratories, Logan, UT, p. 1.
43. Berthois, Y., J. A. Katzenellenbogen, and B. S. Katzenellenbogen. 1986. Phenol red in tissue culture medium is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc. Natl. Acad. Sci. USA 83:2496.
44. Foster, H. L., J. D. Small, and J. G. Fox. 1983. Normative Biology, Immunology and Husbandry. Academic Press, Orlando.
45. Chen, Y., M. Schindler, and S. M. Simon. 1999. A mechanism for tamoxifen-mediated inhibition of acidification. J. Biol. Chem. 274:18364.
46. Morelli, A. E., A. F. Zahorchak, A. T. Larregina, B. L. Colvin, A. J. Logar, T. Takayama, L. D. Falo, and A. W. Thomson. 2001. Cytokine production by mouse myeloid dendritic cells in relation to differentiation and terminal maturation induced by lipopolysaccharide or CD40 ligation. Blood 98:1512.
47. Medina, K. L., A. Strasser, and P. W. Kincade. 2000. Estrogen influences the differentiation, proliferation, and survival of early B-lineage precursors. Blood 95:2059.
48. Medina, K. L., K. P. Garrett, L. F. Thompson, M. I. Rossi, K. J. Payne, and P. W. Kincade. 2001. Identification of very early lymphoid precursors in bone marrow and their regulation by estrogen. Nat. Immun. 2:718.
49. Kouro, T., K. L. Medina, K. Oritani, and P. W. Kincade. 2001. Characteristics of early murine B-lymphocyte precursors and their direct sensitivity to negative regulators. Blood 97:2708.
50. Akashi, K., D. Traver, T. Miyamoto, and I. L. Weissman. 2000. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404:193.
51. Thurmond, T. S., F. G. Murante, J. E. Staples, A. E. Silverstone, K. S. Korach, and T. A. Gasiewicz. 2000. Role of estrogen receptor α in hematopoietic stem cell development and B lymphocyte maturation in the male mouse. Endocrinology 141:2309.
52. Woltman, A. M., J. W. de Fijter, S. W. Kamerling, L. C. Paul, M. R. Daha, and C. van Kooten. 2000. The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells. Eur. J. Immunol. 30:1807.
53. Penna, G., and L. Adorini. 2000. 1α, 25-Dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol. 164:2405.
54. Griffin, M. D., W. Lutz, V. A. Phan, L. A. Bachman, D. J. McKean, and R. Kumar. 2001. Dendritic cell modulation by 1α, 25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc. Natl. Acad. Sci. USA 98:6800.
55. Mooij, P., P. J. Simons, M. de Haan-Meulman, H. J. de Wit, and H. A. Drexhage. 1994. Effect of thyroid hormones and other iodinated compounds on the transition of monocytes into veiled/dendritic cells: role of granulocyte-macrophage colony-stimulating factor, tumor-necrosis factor-α and interleukin-6. J. Endocrinol, 140:503.
56. Liljedahl, M., O. Winqvist, C. D. Surh, P. Wong, K. Ngo, L. Teyton, P. A. Peterson, A. Brunmark, A. Y. Rudensky, W. P. Fung-Leung, and L. Karlsson. 1998. Altered antigen presentation in mice lacking H2-O. Immunity 8:233.
57. Murphy, D. B., S. Rath, E. Pizzo, A. Y. Rudensky, A. George, J. K. Larson, and C. A. Janeway, Jr. 1992. Monoclonal antibody detection of a major self peptide: MHC class II complex. J. Immunol. 148:3483.
58. Simpson, E. R., and M. Dowsett. 2002. Aromatase and its inhibitors: significance for breast cancer therapy. Recent Prog. Horm. Res. 57:317.
59. Grimaldi, C. M., J. Cleary, A. S. Dagtas, D. Moussai, and B. Diamond. 2002. Estrogen alters thresholds for B cell apoptosis and activation. J. Clin. Invest. 109:1625.
60. Favoni, R. E., and A. de Cupis. 1998. Steroidal and nonsteroidal oestrogen antagonists in breast cancer: basic and clinical appraisal. Trends Pharmacol. Sci. 19:406.
61. Voskuhl, R. R. 2002. Gender issues and multiple sclerosis. Curr. Neurol. Neurosci. Rep. 2:277.